Delhi Covid Antibodies
- All
- News
- Videos
-
90% In Delhi Have Covid Antibodies, Shows Sero Survey: Sources
More than 90 per cent of people in Delhi are carrying anti-bodies for coronavirus, sources said after the sixth sero-survey report of the national capital was prepped.
-
Delhi Begins 7th Serological Survey To Detect Covid Antibodies
The seventh round of the serological prevelance survey that seeks to find presence of antibodies against COVID-19 began in New Delhi on Friday amid lower number of coronavirus cases being reported in the city for the past several weeks.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Over Half Of Delhi Has Had Covid, Shows Latest Sero Survey
One in two residents in Delhi has been exposed to the coronavirus and developed antibodies for the infection, the fifth serological survey in the capital has found, the government said on Tuesday. The data suggested that the city of 2 crore is inching towards herd immunity - when the majority of the population becomes immune to a disease, slowing i...
-
Delhi Soon To Have Herd Immunity From Covid, Indicates Sero-Survey
Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...
-
Latest News Live Updates: Delhi Moving Towards Herd Immunity From Covid, Indicates Sero-Survey
Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...
-
Vegetarians May Be At Lower Risk Of Getting Infected By Coronavirus, Says Survey
The study steered by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said that of the 10,427 individuals, 1,058 (10.14 per cent) had antibodies against SARS-CoV-2.
-
August Sero-Survey Finds No Antibodies In 30% Recovered COVID Patients In Delhi
A sero-prevalance survey conducted in the first week of August in Delhi has found that 79 of the 257 people who recovered from COVID-19 did not have antibodies against the virus.
-
97 People, Who Had Been Infected, Didn't Have Covid Antibodies: Delhi Sero Survey
A sero-prevalence survey in Delhi did not find antibodies against the novel coronavirus in the blood of 97 out of 208 people who had previously tested positive for COVID-19, with the National Centre for Disease Control saying it indicates that immune response generated by the virus could be "transient in nature".
-
90% In Delhi Have Covid Antibodies, Shows Sero Survey: Sources
More than 90 per cent of people in Delhi are carrying anti-bodies for coronavirus, sources said after the sixth sero-survey report of the national capital was prepped.
-
Delhi Begins 7th Serological Survey To Detect Covid Antibodies
The seventh round of the serological prevelance survey that seeks to find presence of antibodies against COVID-19 began in New Delhi on Friday amid lower number of coronavirus cases being reported in the city for the past several weeks.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Over Half Of Delhi Has Had Covid, Shows Latest Sero Survey
One in two residents in Delhi has been exposed to the coronavirus and developed antibodies for the infection, the fifth serological survey in the capital has found, the government said on Tuesday. The data suggested that the city of 2 crore is inching towards herd immunity - when the majority of the population becomes immune to a disease, slowing i...
-
Delhi Soon To Have Herd Immunity From Covid, Indicates Sero-Survey
Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...
-
Latest News Live Updates: Delhi Moving Towards Herd Immunity From Covid, Indicates Sero-Survey
Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...
-
Vegetarians May Be At Lower Risk Of Getting Infected By Coronavirus, Says Survey
The study steered by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said that of the 10,427 individuals, 1,058 (10.14 per cent) had antibodies against SARS-CoV-2.
-
August Sero-Survey Finds No Antibodies In 30% Recovered COVID Patients In Delhi
A sero-prevalance survey conducted in the first week of August in Delhi has found that 79 of the 257 people who recovered from COVID-19 did not have antibodies against the virus.
-
97 People, Who Had Been Infected, Didn't Have Covid Antibodies: Delhi Sero Survey
A sero-prevalence survey in Delhi did not find antibodies against the novel coronavirus in the blood of 97 out of 208 people who had previously tested positive for COVID-19, with the National Centre for Disease Control saying it indicates that immune response generated by the virus could be "transient in nature".
